These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6141334)

  • 1. Occupational exposure to cyclophosphamide.
    Hirst M; Tse S; Mills DG; Levin L; White DF
    Lancet; 1984 Jan; 1(8370):186-8. PubMed ID: 6141334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
    Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
    Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
    Hon CY; Teschke K; Shen H; Demers PA; Venners S
    Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.
    Hedmer M; Höglund P; Cavallin-Ståhl E; Albin M; Jönsson BA
    Int Arch Occup Environ Health; 2008 Jan; 81(3):285-93. PubMed ID: 17579883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.
    Evelo CT; Bos RP; Peters JG; Henderson PT
    Int Arch Occup Environ Health; 1986; 58(2):151-5. PubMed ID: 3744569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities.
    Fransman W; Vermeulen R; Kromhout H
    Int Arch Occup Environ Health; 2005 Jun; 78(5):403-12. PubMed ID: 15887018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
    Ensslin AS; Stoll Y; Pethran A; Pfaller A; Römmelt H; Fruhmann G
    Occup Environ Med; 1994 Apr; 51(4):229-33. PubMed ID: 8199663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs.
    Maeda S; Miyawaki K; Matsumoto S; Oishi M; Miwa Y; Kurokawa N
    Yakugaku Zasshi; 2010 Jun; 130(6):903-10. PubMed ID: 20519870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
    Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
    Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity in urine of nurses handling cytostatic drugs.
    Falck K; Gröhn P; Sorsa M; Vainio H; Heinonen E; Holsti LR
    Lancet; 1979 Jun; 1(8128):1250-1. PubMed ID: 87722
    [No Abstract]   [Full Text] [Related]  

  • 11. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.
    Rekhadevi PV; Sailaja N; Chandrasekhar M; Mahboob M; Rahman MF; Grover P
    Mutagenesis; 2007 Nov; 22(6):395-401. PubMed ID: 17855733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of anticancer drugs - Cyclophosphamide and ifosfamide in urine and water sewage samples by gas chromatography-mass spectrometry.
    Lekskulchai V
    Int J Occup Med Environ Health; 2016; 29(5):815-22. PubMed ID: 27518890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.
    Yuki M; Sekine S; Takase K; Ishida T; Sessink PJ
    J Oncol Pharm Pract; 2013 Sep; 19(3):208-17. PubMed ID: 23060485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk assessment concerning hospital personnel participating in the preparation and administration of antineoplastic drugs].
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Frigerio F; Draicchio F; Apostoli P
    G Ital Med Lav Ergon; 1999; 21(2):93-107. PubMed ID: 10771723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of cyclophosphamide in the urine of antineoplastic drugs handlers].
    Favier B; Gilles L; Desage M; Latour JF
    Bull Cancer; 2003 Oct; 90(10):905-9. PubMed ID: 14706919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients.
    Al-Rawithi S; El-Yazigi A; Ernst P; Al-Fiar F; Nicholls PJ
    Bone Marrow Transplant; 1998 Sep; 22(5):485-90. PubMed ID: 9733272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide.
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Draicchio F; Apostoli P
    Rapid Commun Mass Spectrom; 1998; 12(20):1485-93. PubMed ID: 9796535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide.
    Sessink PJ; Kroese ED; van Kranen HJ; Bos RP
    Int Arch Occup Environ Health; 1995; 67(5):317-23. PubMed ID: 8543380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry.
    Kasel D; Jetter A; Harlfinger S; Gebhardt W; Fuhr U
    Rapid Commun Mass Spectrom; 2004; 18(13):1472-8. PubMed ID: 15216508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.